Literature DB >> 1380027

Hepatitis C viremia and anti-HCV antibodies in alcoholics.

B Nalpas1, V Thiers, S Pol, F Driss, V Thepot, P Berthelot, C Brechot.   

Abstract

We determined serum hepatitis C status using a RIBA2 kit and a sensitive PCR procedure in 62 chronic alcoholics, 36 of whom had anti-HCV antibodies (Ab) detectable in an ELISA1 assay. Anti-HCV antibodies were detected in 22 patients using RIBA2. HCV RNA was detected by means of PCR in 18 patients who were RIBA2 positive and in none who were RIBA2 negative. Liver biopsies, available for 12 HCV RNA-positive patients, revealed histological features of purely alcohol-related lesions in seven and mixed alcohol-viral lesions in five. These results indicate that HCV replication is maintained in most alcoholics who score positive for anti-HCV Ab in the RIBA2 test, and that HCV viremia can be associated with histological features typical of alcoholic liver disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380027     DOI: 10.1016/0168-8278(92)90187-t

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

1.  Assessment of liver histology in chronic alcoholics with and without hepatitis C virus infection.

Authors:  S Anderson; C L Nevins; L K Green; H El-Zimaity; B S Anand
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

2.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

3.  How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact.

Authors:  P Sherwood; I Lyburn; S Brown; S Ryder
Journal:  BMJ       Date:  2001-02-03

4.  The management of chronic hepatitis C virus infection.

Authors:  J C Booth; J L Brown; H C Thomas
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

Review 5.  Pathophysiology and treatment of hepatitis C.

Authors:  H C Thomas; J Booth; J Brown
Journal:  Drugs       Date:  1996       Impact factor: 9.546

6.  Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence.

Authors:  Jennifer G Plebani; Carlos F Tirado; Helen M Pettinati; Kyle M Kampman; Joseph R Volpicelli; David W Oslin
Journal:  Addict Behav       Date:  2009-09-10       Impact factor: 3.913

Review 7.  Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.

Authors:  Amedeo Lonardo; Luigi Elio Adinolfi; Luciano Restivo; Stefano Ballestri; Dante Romagnoli; Enrica Baldelli; Fabio Nascimbeni; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

8.  Exploring the combined action of lifetime alcohol intake and chronic hepatotropic virus infections on the risk of symptomatic liver cirrhosis. Collaborative Groups for the Study of Liver Diseases in Italy.

Authors:  G Corrao; P Torchio; A Zambon; P Ferrari; S Aricò; F di Orio
Journal:  Eur J Epidemiol       Date:  1998-07       Impact factor: 8.082

Review 9.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

Review 10.  Alcoholic liver disease and hepatitis C virus infection.

Authors:  Ignacio Novo-Veleiro; Lucía Alvela-Suárez; Antonio-Javier Chamorro; Rogelio González-Sarmiento; Francisco-Javier Laso; Miguel Marcos
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.